Search bioRxiv⌕ Search

Biology subjects

Dos Santos, S. J.

Publications and source records attributed to Dos Santos, S. J..

2 recordsLinked to original sources

Not every gene is special: one simple rule to control the false discovery rate when analysing high-throughput sequencing data

1Differential expression and differential abundance analyses are commonplace in studies employing high-throughput sequencing approaches; however different tools often fail to return comparable results when applied to the same dataset. Most tools employ various normalisations to attempt to correct for technical variation in the count data. Previously, we demonstrated that these normalisations are often inappropriate due to incorrect assumptions regarding the overall scale (i.e. size) of the biological system in question. In this study, we conducted 100 permutation analyses of 10 RNA-seq datasets to show that scale misspecification results in poor control of the false discovery rate by several commonly-used analysis tools. Moreover, we demonstrate that this can be ameliorated by using a scale model in ALDEx2 or ALDEx3 to account for uncertainty around the size of the system scale. We show that there is an inherent trade-off between satisfactory control of false-discovery rates and sensitivity and that no tool offers both. We also quantify how increasing scale uncertainty affects the difference between groups required for a feature to be reported as differentially expressed. Finally, we provide universal guidance on choosing an appropriate amount of scale uncertainty for any type of analysis. Overall, our work highlights the strengths and pitfalls of commonly used tools for differential expression analyses and highlights the choice between sensitivity and false-discovery rate control that all researchers are making when analysing sequencing data.

bioinformatics↗

Vaginal metatranscriptome meta-analysis reveals functional BV subgroups and novel colonisation strategies

The application of -omics technologies to study bacterial vaginosis (BV) has uncovered vast differences in composition and scale between the vaginal microbiomes of healthy and BV patients. Compared to amplicon sequencing and shotgun metagenomic approaches focusing on a single or few species, investigating the transcriptome of the vaginal microbiome at a system-wide level can provide insight into the functions which are actively expressed and differential between states of health and disease. We conducted a meta-analysis of vaginal metatran-scriptomes from three studies, split into exploratory (n = 44) and validation (n = 297) datasets, accounting for the compositional nature of sequencing data and differences in scale between healthy and BV microbiomes. Conducting differential abundance analyses on the exploratory dataset, we identified a multitude of strategies employed by microbes associated with states of health and BV to evade host cationic antimicrobial peptides (CAMPs); putative mechanisms used by BV-associated species to resist and counteract the low vaginal pH; and potential approaches to disrupt vaginal epithelial integrity so as to establish sites for adherence and biofilm formation. Moreover, we identified several distinct functional subgroups within the BV population, distinguished by genes involved in motility, chemotaxis, biofilm formation and co-factor biosynthesis. After defining molecular states of health and BV in the validation dataset using KEGG orthology terms rather than community state types, differential abundance analysis confirmed earlier observations regarding CAMP resistance and compromising epithelial barrier integrity in healthy and BV microbiomes, and also supported the existence of motile vs. non-motile subgroups in the BV population. Our findings highlight a need to focus on functional rather than taxonomic differences when considering the role of microbiomes in disease and identify pathways for further research as potential BV treatment targets.

microbiology↗